AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...

The 340B program spent $43.9 billion in 2021, supporting nearly 50,000 hospitals with discounted outpatient drugs. Cancer drugs constitute 41% of 340B purchases, with outpatient departments and ...

Indiana officials are right to scrutinize how taxpayer dollars are spent, but when it comes to the proposed elimination of the federal 340B drug discount program, the state needs to be cautious. The ...

In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...

PHILADELPHIA, PA, UNITED STATES, February 4, 2026 /EINPresswire.com/ — RxParadigm, an end-to-end 340B drug administration platform with integrated capabilities to ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

PHILADELPHIA, PA, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- RxParadigm, a leading enterprise-grade platform ...

Senate Bill 5981, signed into law by Gov. Bob Ferguson on March 25, strengthened the federal 340B Drug Pricing Program, ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...